| Autor: |
Al-Awsi GRL; Al-Mustaqbal University College, Department of Radiological Techniques, Hillah, Babylon, Iraq., Alameri AA; University of Babylon, College of Science, Department of Chemistry, Babylon, Babylon, Iraq., Al-Dhalimy AMB; Altoosi University College, Department of Nursing, Najaf, Iraq.; The Islamic University, Islamic University Centre for Scientific Research, Najaf, Iraq., Gabr GA; Prince Sattam Bin Abdulaziz University, College of Pharmacy, Department of Pharmacology and Toxicology, Al-Kharj, Al-Kharj, Saudi Arabia.; Agricultural Genetic Engineering Research Institute - AGERI, Agricultural Research Center, Giza, Egypt., Kianfar E; Islamic Azad University, Department of Chemistry, Sousangerd, Iran.; Istanbul Medeniyet University, Department of Mechanical Engineering, Istanbul, Turkey.; Islamic Azad University, Department of Chemical Engineering, Arak, Iran.; Islamic Azad University, Young Researchers and Elite Club, Gachsaran, Iran. |
| Abstrakt: |
Infectious diseases are the leading cause of death worldwide. Thus, nanotechnology provides an excellent opportunity to treat drug-resistant microbial infections. Numerous antibiotics have been used to inhibit the growth and kill of microbes, but the development of resistance and the emergence of side effects have severely limited the use of these agents. Due to the development of the nanotechnology, nanoparticles are widely used as antimicrobials. Silver and chitosan nanoparticles have antifungal, antiviral and antibacterial properties, and many studies confirm the antifungal properties of silver nanoparticles. Nowadays, the use of nanoparticles in the diagnosis and treatment of infectious diseases has developed due to less side effects and also the help of these particles in effective drug delivery to the target tissue. Liposomes are also used as carriers of drug delivery, genes, and modeling of cell membranes in both animals and humans. The ability of these liposomes to encapsulate large amounts of drugs, minimize unwanted side effects, high effectiveness and low toxicity has attracted the interest of researchers. This review article examines recent efforts by researchers to identify and treat infectious diseases using antimicrobial nanoparticles and drug nano-carriers. |
